House Committees Launch Investigation Into Alzheimer's Drug

Published July 1, 2021 at 12:40 PM CDT

Two House committees are now investigating the drug aducanumab, which was approved by the Food and Drug Administration to treat Alzheimer’s disease.

Here & Now‘s Peter O’Dowd talks withDamian Garde, a reporter at STAT.

This article was originally published on WBUR.org.